Literature DB >> 33251567

Iterative Development of Clinician Guides to Support Deprescribing Decisions and Communication for Older Patients in Hospital: A Novel Methodology.

M H Duong1, A J McLachlan2, A A Bennett3, N Jokanovic1, D G Le Couteur4, M T Baysari5, D Gnjidic2, F Blyth6, S N Hilmer7.   

Abstract

BACKGROUND/
OBJECTIVES: Medication review is an important component of the management of older hospital patients. Deprescribing (supervised withdrawal of inappropriate medicines) is one outcome of review. This study aimed to iteratively develop and test the usability of deprescribing guides, which support multidisciplinary clinicians to reduce inappropriate polypharmacy in older inpatients.
METHODS: Deprescribing guides for hospital clinicians were developed using a novel mixed-methods, ten-step process. Iterative development and usability testing were applied. This included content development through review of the literature; expert consensus through five rounds of feedback using a modified Delphi approach; and usability testing by 16 multidisciplinary hospital clinicians on hypothetical clinical scenarios involving observations, semi-structured interviews, and administration of the System Usability Scale.
RESULTS: This novel process was used to develop deprescribing guides that facilitate implementation of evidence on deprescribing in routine hospital care. The guides present evidence-based information in a format that aligns with workflows of multidisciplinary hospital clinicians. The guides were adapted for various clinical roles to navigate efficiently to suit differing workflow needs. Guides include unique communication support in the form of "preferred language". Clinicians can use the "preferred language" to apply the evidence to the individual patient and relay decisions between health providers and with patients/carers. The total System Usability Scale score was 80.6 ± 2.0 (mean ± standard error of the mean), indicating excellent usability. Guides have been developed using consistent format for nine medication classes that are common targets for deprescribing and are publicly available.
CONCLUSION: This study demonstrates a novel approach to the development and implementation of evidence-based recommendations that support deprescribing in routine hospital care.

Entities:  

Year:  2020        PMID: 33251567     DOI: 10.1007/s40266-020-00820-8

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  14 in total

1.  The effects of polypharmacy in older adults.

Authors:  S N Hilmer; D Gnjidic
Journal:  Clin Pharmacol Ther       Date:  2008-11-26       Impact factor: 6.875

Review 2.  A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice.

Authors:  Emily Reeve; Danijela Gnjidic; Janet Long; Sarah Hilmer
Journal:  Br J Clin Pharmacol       Date:  2015-12       Impact factor: 4.335

3.  Too much medicine in older people? Deprescribing through shared decision making.

Authors:  Jesse Jansen; Vasi Naganathan; Stacy M Carter; Andrew J McLachlan; Brooke Nickel; Les Irwig; Carissa Bonner; Jenny Doust; Jim Colvin; Aine Heaney; Robin Turner; Kirsten McCaffery
Journal:  BMJ       Date:  2016-06-03

4.  Attitudes of Older Adults and Caregivers in Australia toward Deprescribing.

Authors:  Emily Reeve; Lee-Fay Low; Sarah N Hilmer
Journal:  J Am Geriatr Soc       Date:  2019-02-13       Impact factor: 5.562

5.  Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States.

Authors:  Emily Reeve; Jennifer L Wolff; Maureen Skehan; Elizabeth A Bayliss; Sarah N Hilmer; Cynthia M Boyd
Journal:  JAMA Intern Med       Date:  2018-12-01       Impact factor: 21.873

6.  A drug burden index to define the functional burden of medications in older people.

Authors:  Sarah N Hilmer; Donald E Mager; Eleanor M Simonsick; Ying Cao; Shari M Ling; B Gwen Windham; Tamara B Harris; Joseph T Hanlon; Susan M Rubin; Ronald I Shorr; Douglas C Bauer; Darrell R Abernethy
Journal:  Arch Intern Med       Date:  2007-04-23

7.  Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial.

Authors:  Denis O'Mahony; Adalsteinn Gudmundsson; Roy L Soiza; Mirko Petrovic; Alfonso Jose Cruz-Jentoft; Antonio Cherubini; Richard Fordham; Stephen Byrne; Darren Dahly; Paul Gallagher; Amanda Lavan; Denis Curtin; Kieran Dalton; Shane Cullinan; Evelyn Flanagan; Frances Shiely; Olafur Samuelsson; Astros Sverrisdottir; Selvarani Subbarayan; Lore Vandaele; Eline Meireson; Beatriz Montero-Errasquin; Aurora Rexach-Cano; Andrea Correa Perez; Isabel Lozano-Montoya; Manuel Vélez-Díaz-Pallarés; Annarita Cerenzia; Samanta Corradi; Maria Soledad Cotorruelo Ferreiro; Federica Dimitri; Paolo Marinelli; Gaia Martelli; Rebekah Fong Soe Khioe; Joseph Eustace
Journal:  Age Ageing       Date:  2020-07-01       Impact factor: 10.668

8.  Decision Making for Older Adults With Multiple Chronic Conditions: Executive Summary for the American Geriatrics Society Guiding Principles on the Care of Older Adults With Multimorbidity.

Authors:  Cynthia Boyd; Cynthia Daisy Smith; Frederick A Masoudi; Caroline S Blaum; John A Dodson; Ariel R Green; Amy Kelley; Daniel Matlock; Jennifer Ouellet; Michael W Rich; Nancy L Schoenborn; Mary E Tinetti
Journal:  J Am Geriatr Soc       Date:  2019-03-10       Impact factor: 5.562

Review 9.  A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.

Authors:  Tariq M Alhawassi; Ines Krass; Beata V Bajorek; Lisa G Pont
Journal:  Clin Interv Aging       Date:  2014-12-01       Impact factor: 4.458

10.  Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing.

Authors:  Barbara Farrell; Kevin Pottie; Carlos H Rojas-Fernandez; Lise M Bjerre; Wade Thompson; Vivian Welch
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.